Mounjaro 2.5mg Vial Of 0.5ml Solution For Injection
Description
Mounjaro 2.5 injection is a prescription medication used to improve blood sugar control in adults with type 2 diabetes when used in conjunction with diet and exercise. It is also indicated for weight management when used in conjunction with a reduced-calorie diet and increased physical activity. It contains tirzepatide as its active ingredient. It should be administered as directed by your doctor. Your doctor will clearly explain how to adjust the dosage and administer the medication.
Common side effects of Mounjaro 2.5 injection may include nausea, diarrhoea, vomiting, constipation, abdominal pain, and indigestion. These symptoms are generally mild and tend to improve over time. However, if they become severe or persist for an extended period, it's essential to consult a doctor.
Mounjaro is supplied as an injectable solution, presented in pre-filled single-dose pens or single-dose vials available in a range of strengths to accommodate varying dosing needs. These strengths include 2.5 mg/0.5 mL, 5 mg/0.5 mL (Mounjaro 5 mg injection), 7.5 mg/0.5 mL, 10 mg/0.5 mL, 12.5 mg/0.5 mL, and 15 mg/0.5 mL.
It is not recommended for those with a personal or family history of medullary thyroid carcinoma or multiple endocrine neoplasia syndrome type 2 (MEN2). Pregnant individuals or those planning to conceive should avoid this medication due to potential risks to the developing baby.
Before starting this treatment, please inform your doctor of all other medications you are taking to prevent interactions.
Product Summary
Offer Price | ₹3500.00 |
You Save | |
Contains | Tirzepatide(2.5 Mg/0.5ml) |
Uses | Type 2 diabetes mellitus |
Side effects | Nausea, diarrhea, decreased appetite, vomiting, constipation, dyspepsia, and abdominal pain. |
Therapy | ANTI-DIABETIC |
Uses
Contraindications
Side effects
- Abdominal pain
- Constipation
- Indigestion
- Nausea
- Diarrhea
- Vomiting
Precautions and Warnings
Pregnancy
Breast Feeding
Driving
Alcohol
Other General Warnings
- You have a history of pancreatitis.
- You experience severe abdominal pain, nausea, or vomiting, which could indicate pancreatitis.
- You have type 2 diabetes and are taking insulin or a sulfonylurea, as you may be at an increased risk of hypoglycemia.
- You experience frequent nausea, vomiting, or diarrhoea, which may lead to dehydration and kidney issues.
- You have kidney disease, have had a kidney transplant, or have liver disease.
- You are elderly, especially if you are over 85 years old, as there is limited data on safety in this age group.
- You have severe gastrointestinal disease, including gastroparesis, as this injection has not been studied in such patients.
- You have diabetic retinopathy or diabetic macular oedema, as this injection should be used cautiously in these conditions.
- You are scheduled for a procedure requiring general anaesthesia or deep sedation, as there is an increased risk of pulmonary aspiration.
- You notice any unusual changes in your vision while using this injection.
Directions for Use
- Use Mounjaro 2.5 injection as directed by your doctor. Rotate injection sites with each dose.
- Choose your injection site; your healthcare provider can assist you in selecting the one that is best for you. You or someone else can inject the medicine into your stomach, thighs, or the back of your upper arms....
- If another person is administering the injection, it should be given in the back of your upper arm.
- Remove the base cap. Place the base flat against your skin, then release the lock. Press and hold the button for up to 10 seconds. Listen for the first click, which indicates that the injection has started. The second click signifies that the injection is complete....
Storage and disposal
- Store Mounjaro 2.5 injection in a refrigerator at a temperature between 2°C and 8°C.
- If necessary, each single-dose pen or vial can be stored unrefrigerated at temperatures not exceeding 30 °C for up to 21 days.
- Do not freeze. Do not use if frozen.
- Store it in the original carton to protect it from light.
Quick Tips
- To help keep your blood sugar levels steady, take Mounjaro 2.5 injection on the same day each week. Setting a reminder can assist you in staying on track.
- Rotate your injection sites (abdomen, thigh, or upper arm) weekly to avoid skin irritation, bruising, or lumps.
- Regularly check your blood sugar to monitor for signs of low blood sugar, especially if you are on other diabetes medications.
- Eat small, frequent, and balanced meals, and avoid greasy or heavy foods to minimize nausea. Make sure to stay hydrated by drinking plenty of water, especially if you experience nausea, vomiting, or diarrhea....
- Be aware of serious side effects such as intense stomach pain, signs of pancreatitis (like pain radiating to the back with nausea or fever), or allergic reactions. Contact your doctor immediately if any of these occur....
- Mounjaro 2.5 injection may interfere with oral contraceptives. To prevent unintended pregnancy, use a backup birth control method (such as condoms) or switch to a non-oral contraceptive for four weeks after starting treatment and for four weeks after any dose increase....
- Inform your doctor or surgeon that you’re using Mounjaro 2.5 injection if you have surgery scheduled, as it may slow down how your stomach empties and increase the risk of complications during anesthesia....
Dosage
Overdose
Missed a Dose
Mode of Action
How Does It Work?
Interactions
Interactions with other medicines
- Taking oral medications with a narrow therapeutic index, such as warfarin or digoxin, may be affected by tirzepatide, as it can alter their absorption.
- Using medications that require a rapid onset of action might be problematic since this injection may delay their effects.
- Relying on oral contraceptives may be risky, as this injection could reduce their effectiveness. It is advisable to consider switching to a non-oral contraceptive method or to use additional protection for four weeks after starting or increasing the dose....
- Having obesity or being overweight while using oral contraceptives may raise concerns, as this can affect their efficacy.
- Frequent use of paracetamol may be impacted by this injection, as it may delay its absorption; however, no dose adjustment is typically necessary.
Content Details

Ravindra Ghongade
B. Pharm

Dr. Nikita Toshi
BDS (Bachelor of Dental Surgery), WHO FIDES member
Frequently Asked Questions (FAQs)
Q: What are the most common side effects of Mounjaro 2.5 injection I should be aware of?
Q: Will Mounjaro 2.5 injection interact with other medications I am taking?
Q: What is the price of Mounjaro 2.5 injection in India?
Q: Is Mounjaro 2.5 injection used for weight loss?
Q: What is Mounjaro 2.5 injection, and what is it used for?
Q: How does Mounjaro 2.5 injection work?
Q: Is Mounjaro 2.5 injection an insulin?
Q: How is Mounjaro 2.5 injection administered?
Q: Can Mounjaro 2.5 injection cause low blood sugar (hypoglycemia)?
Q: Who should not use Mounjaro 2.5 injection?
Q: Can Mounjaro 2.5 injection be used during pregnancy or breastfeeding?
Q: Do I have to take Mounjaro 2.5 injection for the rest of my life?
Q: What happens when you stop taking Mounjaro 2.5 injection?
Q: Can I take Mounjaro 2.5 injection with other diabetes medications?
Q: Are there any precautions to follow while taking Mounjaro 2.5 injection?
- Yes, some important precautions include:
- Monitor for low blood sugar if you're taking other diabetes medications.
- Stay hydrated, particularly if you experience stomach upset.
- Avoid or limit alcohol, as it can increase the risk of low blood sugar or dehydration.
- Inform your doctor if you have a history of pancreatitis, kidney disease, or severe gastrointestinal issues.
- If you're undergoing surgery, notify your doctor that you're taking Mounjaro 2.5 injection, as it can slow stomach emptying and may need to be suspended prior to the procedure.
- For women using oral birth control, discuss alternative or additional contraception with your doctor.
References
- Lilly.com | Eli Lilly and Company [Internet]. www.lilly.com. [Cited 6th June 2025]
- Mounjaro KwikPen 2.5mg solution for injection in pre-filled pen - Summary of Product Characteristics (SmPC) - (emc) [Internet]. www.medicines.org.uk. [Cited 6th June 2025]
- MOUNJAROTM (tirzepatide) Injection, for subcutaneous use Initial U.S. Approval: 2022 [Internet]. uspl.lilly.com. [Cited 6th June 2025]
- Central Drugs Standard Control Organization (CDSCO). Drugs [Internet]. New Delhi: Central Drugs Standard Control Organization; [cited 2025 Jun 6].
Did you find this medicine information helpful?
Please rate your experience